Elafibranor
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 156 publications
Long-term Treatment With Elafibranor Leads to Biochemical and Symptomatic Improvements for at Least 3 Years in Patients With PBC.
Journal: Gastroenterology & hepatology
Published: February 09, 2026
Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis.
Journal: Annals of gastroenterology
Published: December 24, 2025
Meta-Analysis: PPAR Agonists for Pruritus and Quality of Life in Primary Biliary Cholangitis.
Journal: Alimentary pharmacology & therapeutics
Published: December 10, 2025
Baseline Alkaline Phosphatase Impacts Response Rates in Primary Biliary Cholangitis: Exploring Response to Elafibranor in ELATIVE.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 05, 2025
Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary Cholangitis.
Journal: Alimentary pharmacology & therapeutics
Published: October 21, 2025
Recent Advances in Primary Biliary Cholangitis Treatment.
Journal: Clinics in liver disease
Published: October 18, 2025
An update on novel investigational agents for the treatment of primary biliary cholangitis.
Journal: Expert opinion on investigational drugs
Published: October 13, 2025
Phase II clinical trials in primary sclerosing cholangitis: Making the most of every opportunity?
Journal: Journal of hepatology
Published: October 07, 2025
Small molecule screen identifies elafibranor to link mechanical cues and IRF6-dependent epithelial differentiation.
Journal: Disease models & mechanisms
Published: September 08, 2025
A small-molecule screen identifies that elafibranor links mechanical cues and Irf6-dependent epithelial differentiation.
Journal: Disease models & mechanisms
Published: September 08, 2025
Primary biliary cholangitis. Treatment options in 2025. A narrative review.
Journal: Frontiers in immunology
Published: September 04, 2025
Last Updated: 04/28/2026